Search research articles
Contact Us
Filters
Showing results (41-50 of 60) with videos related to
Page
of 6
Sort By:
The Journal of Membrane Biology
|
January 1, 1973
Barriers to sodium movement across frog skin
J H Moreno, I L Reisin, E Rodríguez Boulan, et al.
American Heart Journal
|
August 2, 2001
The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure
C Schalcher, G Cotter, L Reisin, et al.
American Journal of Therapeutics
|
July 29, 1999
Safety of prostaglandin E1 for the treatment of peripheral arterial occlusive disease in patients with congestive heart failure. The Alprostadil Investigators
L Reisin, A Marmor, B Rabinowitz, et al.
Journal of Human Hypertension
|
December 1, 1999
Prior antihypertensive treatment and admission blood pressure correlated with clinical outcome and early morning presentation in hypertensive ischaemic stroke patients
C Yosefy, L Linov, J R Viskoper, et al.
The American Journal of Cardiology
|
March 15, 1997
Comparison of short- and long-term prognosis in patients with anterior wall versus inferior or lateral wall non-Q-wave acute myocardial infarction. Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) Study Group
M Haim, H Hod, L Reisin, et al.
American Heart Journal
|
March 7, 1998
Adding the new calcium antagonist mibefradil to patients receiving long-term beta-blocker therapy results in improved antianginal and antiischemic efficacy
A Schneeweiss, I Kobrin, V Charlon, et al.
Cardiology
|
September 1, 1997
Prognostic significance of infarction location in patients with recurrent myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israel Nifedipine Trial
R Kornowski, U Goldbourt, H Reicher-Reiss, et al.
The Journal of Biological Chemistry
|
August 12, 1994
The cystic fibrosis transmembrane conductance regulator is a dual ATP and chloride channel
I L Reisin, A G Prat, E H Abraham, et al.
Journal of Clinical Epidemiology
|
June 1, 1995
Plasma fibrinogen levels and their correlates in 6457 coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study
E Barasch, M Benderly, E Graff, et al.
American Journal of Therapeutics
|
July 29, 1999
Prostaglandin E1 : electrophysiological safety in patients with congestive heart failure and peripheral arterial occlusive disease. The Alprostadil Investigators
J C Somberg, V Yelamanchi, J Molnar, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 60) with videos related to
Sort By:
Page
of 6
The Journal of Membrane Biology
|
January 1, 1973
Barriers to sodium movement across frog skin
J H Moreno, I L Reisin, E Rodríguez Boulan, et al.
American Heart Journal
|
August 2, 2001
The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure
C Schalcher, G Cotter, L Reisin, et al.
American Journal of Therapeutics
|
July 29, 1999
Safety of prostaglandin E1 for the treatment of peripheral arterial occlusive disease in patients with congestive heart failure. The Alprostadil Investigators
L Reisin, A Marmor, B Rabinowitz, et al.
Journal of Human Hypertension
|
December 1, 1999
Prior antihypertensive treatment and admission blood pressure correlated with clinical outcome and early morning presentation in hypertensive ischaemic stroke patients
C Yosefy, L Linov, J R Viskoper, et al.
The American Journal of Cardiology
|
March 15, 1997
Comparison of short- and long-term prognosis in patients with anterior wall versus inferior or lateral wall non-Q-wave acute myocardial infarction. Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) Study Group
M Haim, H Hod, L Reisin, et al.
American Heart Journal
|
March 7, 1998
Adding the new calcium antagonist mibefradil to patients receiving long-term beta-blocker therapy results in improved antianginal and antiischemic efficacy
A Schneeweiss, I Kobrin, V Charlon, et al.
Cardiology
|
September 1, 1997
Prognostic significance of infarction location in patients with recurrent myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israel Nifedipine Trial
R Kornowski, U Goldbourt, H Reicher-Reiss, et al.
The Journal of Biological Chemistry
|
August 12, 1994
The cystic fibrosis transmembrane conductance regulator is a dual ATP and chloride channel
I L Reisin, A G Prat, E H Abraham, et al.
Journal of Clinical Epidemiology
|
June 1, 1995
Plasma fibrinogen levels and their correlates in 6457 coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study
E Barasch, M Benderly, E Graff, et al.
American Journal of Therapeutics
|
July 29, 1999
Prostaglandin E1 : electrophysiological safety in patients with congestive heart failure and peripheral arterial occlusive disease. The Alprostadil Investigators
J C Somberg, V Yelamanchi, J Molnar, et al.
Page
of 6